Achira Labs is a immunodiagnostics company focussed on developing point-of-care diagnostics solutions for developing countries. Achira’s ACIX100 is a microfluidics platform which combines a plastic disposable cartridge containing dry reagents and a desktop reader instrument. ACIX100’s rapid turn around time, low costs and minimal infrastructure and manpower requirements make it very suitable for rural and semi-urban areas that are under-served by large centralised diagnostics labs. ACIX 100 has been clinically validated for 7 tests in thyroid and fertility, along with a large menu of tests including infectious diseases under development.
Achira leverages its expertise to provide technological services to customers in the medical devices sector. Achira’s expertise includes microfluidics research and development, design and prototyping, instrumentation, assay development and manufacturing. Achira is a 35 person company with a strong R&D focus. Achira has raised funds from Catamaran Ventures, Grand Challenges Canada and BIRAC (Govt. of India). Achira was founded in 2009 and is based in Bangalore, India.